Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Qiagen N.V. (NY: QGEN ) 45.24 +0.22 (+0.49%) Official Closing Price Updated: 7:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Qiagen N.V. < Previous 1 2 3 4 5 6 Next > Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 June 03, 2021 Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... Via Benzinga Amgen's First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer May 28, 2021 The FDA has given accelerated approval to Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras... Via Benzinga Exposures Product Safety Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer May 28, 2021 From QIAGEN N.V. Via Business Wire The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing May 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... Via Benzinga QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRASG12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC) May 25, 2021 From QIAGEN N.V. Via Business Wire QIAGEN Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021 May 17, 2021 From QIAGEN N.V. Via Business Wire QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies May 12, 2021 From QIAGEN N.V. Via Business Wire The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use May 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 Qiagen NV (QGEN) Q1 2021 Earnings Call Transcript May 05, 2021 QGEN earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Qiagen Q1 Earnings Tops Estimates As Growth In Non-COVID-19 Products Boost Revenues May 04, 2021 Qiagen NV (NYSE: QGEN) on Monday after-hours reported first-quarter revenue growth of 52% Y/Y to $567.2 million, exceeding prior guidance and beating analyst... Via Benzinga Recap: Qiagen Q1 Earnings May 03, 2021 Shares of Qiagen (NYSE:QGEN) quite in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 94.12% year over year to $0.66... Via Benzinga QIAGEN Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profitability Outlook for Full-Year 2021 May 03, 2021 From QIAGEN N.V. Via Business Wire Qiagen's Earnings: A Preview April 30, 2021 On Monday, May 03, Qiagen (NYSE:QGEN) will release its latest earnings report. Decipher the announcement with Benzinga's help. Net Income, Earnings, And Earnings Per Share... Via Benzinga Earnings Scheduled For May 3, 2021 May 03, 2021 Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •... Via Benzinga QIAGEN Announces EZ2 Connect Instrument Line for Automated Sample Processing in Research, Forensics and Diagnostics April 29, 2021 From QIAGEN N.V. Via Business Wire QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme Borreliosis April 21, 2021 From QIAGEN N.V. Via Business Wire QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity April 20, 2021 From QIAGEN N.V. Via Business Wire QIAGEN N.V. to Report First Quarter 2021 Results April 20, 2021 From QIAGEN N.V. Via Business Wire What Does Qiagen's Debt Look Like? April 12, 2021 Over the past three months, shares of Qiagen (NYSE:QGEN) decreased by 3.68%. Before having a look at the importance of debt, let us look at how much debt Qiagen has. Qiagen... Via Benzinga The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award April 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ... Via Benzinga Topics Intellectual Property Exposures Intellectual Property QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance April 06, 2021 From QIAGEN N.V. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.